Athersys Inc (ATHXQ)

[edwick709]

1)The 6 scientific papers given at the INTERNATIONAL Stroke CONF.(Feb 2016) on various aspects(eg cost efficaccy etc) of the 365 day follow up of the randomized double blind gold standard study of Multistem(ATHX) PROVE that if Multistem cell therapy is administered within 36 hours of a stroke an EXCELLENT outcome is very likely(p= <0.02).
2)The DELAYED MECHANISM of healing is the REDUCTION in multiple types of specific cytokines(biomarkers) that reduce inflammation and secondary infections(p= <0.02).
3)Helios-Japan now a clear glide path (New 2015, Regenerative Medicine law in Japan) to provisional APPROVAL and commercialization.